Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunitybio Inc (NQ: IBRX )

1.650 +0.020 (+1.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,466,776
Open 1.630
Bid (Size) 1.600 (10)
Ask (Size) 1.650 (282)
Prev. Close 1.630
Today's Range 1.570 - 1.650
52wk Range 1.210 - 7.100
Shares Outstanding 391,156,513
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916. 
Via Benzinga
Why Shares of ImmunityBio Jumped This Week
The company's founder is spending his own money to help finance the business's efforts. 
Via The Motley Fool

Performance

YTD
-65.41%
-65.41%
1 Month
+3.12%
+3.12%
3 Month
-36.29%
-36.29%
6 Month
-3.51%
-3.51%
1 Year
-65.84%
-65.84%

More News

Read More
Casey's General Stores, Cognyte Software, Beauty Health And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
ImmunityBio Announces $470 Million Equity and Debt Financing From Founder, Dr. Patrick Soon-Shiong and Nant Entities
From ImmunityBio, Inc.
Via Business Wire
IBRX DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important August 29 Deadline in Securities Class Action – IBRX
From The Rosen Law Firm, P.A.
Via Business Wire
3 Very Oversold Biotech Stocks to Buy Right Now
Via InvestorPlace
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ImmunityBio, Inc. (IBRX)
From The Law Offices of Frank R. Cruz
Via Business Wire
NASDAQ:IBRX Investor Notice: Deadline on August 29, 2023 in Lawsuit Against ImmunityBio, Inc.
Via SBWire
Topics Lawsuit
Exposures Financial Legal
IBRX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
IMMUNITYBIO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
IBRX FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
IMMUNITYBIO, INC. (NASDAQ: IBRX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ImmunityBio, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ImmunityBio, BioXcel, and Seagate and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A TOP RANKED FIRM, Encourages ImmunityBio, Inc. Investors With Losses to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ImmunityBio, BioXcel, and Seagate and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
IBRX DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ImmunityBio, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
ROSEN, LEADING TRIAL ATTORNEYS, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GDS, Arrow, ImmunityBio, and BioXcel and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - IBRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NASDAQ: IBRX Shareholder Alert: Lawsuit Alleges Misleading Statements by ImmunityBio, Inc.
Via SBWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
IMMUNITYBIO, INC. (NASDAQ: IBRX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ImmunityBio, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.